About Invitae Company
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Invitae Aims to Regain NYSE Compliance After Average Share Price Falls Below $1
Invitae Receives Notice of Non-Compliance With NYSE Minimum Share Price Continued Listing Standard
SAN FRANCISCO, Sept. 22, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it received a notice from the New York Stock Exchange (the "NYSE") on Sept
Novavax and Invitae Implement Cost-cutting Measures Amid Financial Challenges